Seasonal influenza vaccines
ATAGI has issued updated advice on the relative timing of administering influenza vaccines and COVID-19 vaccines in 2021.
The preferred minimum interval between a dose of influenza vaccine and a dose of either Pfizer vaccine or AstraZeneca vaccine is now 7 days (previously 14 days).
In some situations, a shorter interval (including co-administration) is acceptable.
Read more about this change in the updated:
- ATAGI advice on seasonal influenza vaccines in 2021
- Clinical advice for vaccination providers – 2021 influenza vaccines
Vaccination providers are reminded that it is now mandatory to report all influenza vaccinations to the Australian Immunisation Register.
COVID vaccination for pregnant women
A joint statement by RANZCOG and ATAGI recommends that pregnant women are routinely offered Pfizer at any stage of pregnancy. This is because the risk of severe outcomes from COVID-19 is significantly higher for pregnant women and their unborn baby.
Global surveillance data from large numbers of pregnant women have not identified any significant safety concerns with mRNA COVID-19 vaccines given at any stage of pregnancy. Furthermore, there is also evidence of antibody in cord blood and breastmilk, which may offer protection to infants through passive immunity.
Pregnant women are encouraged to discuss the decision in relation to timing of vaccination with their health professional.
Women who are trying to become pregnant do not need to delay vaccination or avoid becoming pregnant after vaccination.